Search Within

Kevin Joseph Curran

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (9)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (38)
  2. Department of Medicine (38)
  3. GSK Faculty (38)
  4. Hematologic Malignancies Research (38)
  5. Molecular Pharmacology and Chemistry Program Faculty (38)
  6. Pediatrics, Department of (38)

More Groups

People
  1. Isabelle Riviere (36)
  2. Michel Sadelain (36)
  3. Renier Brentjens (32)
  4. Jae Park (28)
  5. Xiuyan Wang (27)
  6. Craig Sauter (17)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (5)

More Years

Publications
  1. Blood (14)
  2. Journal of Clinical Oncology (3)
  3. Molecular Therapy (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. Bone Marrow Transplantation (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Nature Publishing Group (7)
  3. American Society of Clinical Oncology (3)
  4. American Association for Cancer Research (2)
  5. American Association for the Advancement of Science (2)
  6. Elsevier Inc. (2)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y. J.; Yoo, S.; Purdon, T.; Halton, E.; Quintanilla, H.; Curran, K. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; Stefanski, J.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
    Journal Article

    Brentjens, R. J.; Davila, M. L.; Riviere, I.; Park, J.; Wang, X.; Cowell, L. G.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • CD19 targeted allogeneic EBV-specific T cells for the treatment of relapsed ALL in pediatric patients post HSCT
    Meeting Abstract

    Curran, K. J.; Kernan, N. A.; Wang, X. Y.; Taylor, C.; Doubrovina, E.; Bartido, S.; Sadelain, M.; O'Reilly, R. J.; Brentjens, R. J.; Riviere, I.
    Blood (2012)

    Fulltext@MSK | Save
  • Virus specific T-lymphocytes genetically modified to target the CD19 antigen eradicates systemic lymphoma in mice
    Meeting Abstract

    Curran, K. J.; Taylor, C.; Doubrovina, E.; Wang, X.; O'Reilly, R. J.; Sadelain, M.; Kernan, N. A.; Brentjens, R. J.; Riviere, I.
    Blood (2010)

    Fulltext@MSK | Save